Ergocalciferol
- Generic Name
- Ergocalciferol
- Brand Names
- Drisdol, Mvi Pediatric
- Drug Type
- Small Molecule
- Chemical Formula
- C28H44O
- CAS Number
- 50-14-6
- Unique Ingredient Identifier
- VS041H42XC
- Background
Ergocalciferol is an inactivated vitamin D analog. It is synthesized by some plants in the presence of UVB light. The production of ergocalciferol was prompted by the identification of dietary deficiency, more specifically vitamin D, as the main causative factor for the development of rickets. Ergocalciferol was isolated for the first time from yeast in 1931...
- Indication
Ergocalciferol is indicated for the treatment of hypoparathyroidism, refractory rickets, and familial hypophosphatemia.
Hypoparathyroidism is the result of inadequate parathyroid hormone production that occurs due to the presence of damage or removal of the parathyroid glands. This condition produces decreased calcium and increased phosphorus levels.
...
- Associated Conditions
- Deficiency, Vitamin A, Deficiency, Vitamin D, Hypoparathyroidism, Hypophosphatemia, Familial, Vitamin D Resistant Rickets
- Associated Therapies
- Dietary supplementation
Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity
- Conditions
- First Posted Date
- 2006-02-08
- Last Posted Date
- 2018-12-20
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 60
- Registration Number
- NCT00288873
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Effects of Vitamin D Supplementation on Antimycobacterial Immunity
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2007-01-08
- Lead Sponsor
- Barts & The London NHS Trust
- Target Recruit Count
- 230
- Registration Number
- NCT00157066
- Locations
- 🇬🇧
Tuberculosis Clinic, Newham Chest Clinic, London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.